Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system
Emma J. Meader, Melinda J. Mayer, Michael J. Gasson, Dietmar Steverding, Simon R. Carding, Arjan Narbad
Abstract
Emma J. Meader, Melinda J. Mayer, Michael J. Gasson, Dietmar Steverding, Simon R. Carding, Arjan Narbad
Abstract
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 64 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Microbiology, Clostridium difficile, Metronidazole, Antibiotics, Clostridium, Clostridium difficile toxin A, Biology, Bifidobacterium